Change in Quality of Life After Addition of Weekly 40 mg Pegvisomant/Placebo in Controlled Acromegalic Patients - Related Studies

Change in Quality of Life After Addition of Weekly 40 mg Pegvisomant/Placebo in Controlled Acromegalic Patients (mec-2005-290)

This study has been completed.

Study NCT00642720 Information provided by Erasmus Medical Center

First Received: March 21, 2008 Last Updated: March 24, 2008 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Quality of Life
Acromegaly

More general conditions related to this trial

Interventions listed in this trial

Pegvisomant

Sponsors listed in this trial